This inventor holds 1 USPTO granted patent. Top assignees: Chang Gung Memorial Hospital, Linkou, Ming Chi University of Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Chi-Yun Wang in Glass-Ceramic Composite Materials
Introduction
Chi-Yun Wang is an accomplished inventor based in New Taipei, Taiwan. He has made significant contributions to the field of materials science, particularly in the development of glass-ceramic composite materials. His innovative work focuses on creating materials that possess both degradability and osteoconductivity, which are essential for various biomedical applications.
Latest Patents
Chi-Yun Wang holds a patent for a glass-ceramic composite material. This invention relates to a composite material that is composed of CaO—MgO—SiO (CMS glass) combined with CaMgSiO (CMS ceramic) and CaSO (CS ceramic). The synthesized composite material features high mechanical strength, biocompatibility, and osteoconductivity. Additionally, the CaSO component is characterized by its rapid degradation, which promotes bone ingrowth, making it a valuable material in medical applications.
Career Highlights
Throughout his career, Chi-Yun Wang has worked with notable institutions such as Chang Gung Memorial Hospital in Linkou and Ming Chi University of Technology. His experience in these organizations has allowed him to apply his research in practical settings, contributing to advancements in medical materials.
Collaborations
Chi-Yun Wang has collaborated with esteemed colleagues, including Shyang-Yih Kung and Yu-Jie Wu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative materials.
Conclusion
Chi-Yun Wang's contributions to the field of glass-ceramic composite materials highlight his role as a leading inventor in materials science. His patented innovations demonstrate the potential for significant advancements in biomedical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile